Takeda Pharmaceutical (TAK) Net Margin Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | -3,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.00 |
| Mar 31, 2026 | 26.00 |
| Dec 31, 2025 | -4,453.00 |
| Sep 30, 2025 | -4.00 |
| Jun 30, 2025 | 43.00 |
| Mar 31, 2025 | 1,145.00 |
| Dec 31, 2024 | -1,621.00 |
| Sep 30, 2024 | 54.00 |
| Jun 30, 2024 | -661.00 |
| Mar 31, 2024 | -1,771.00 |
| Dec 31, 2023 | -808.00 |
| Sep 30, 2023 | 839.00 |
| Jun 30, 2023 | -185.00 |
| Mar 31, 2023 | 972.00 |
| Sep 30, 2022 | -219.00 |
| Jun 30, 2022 | 997.00 |
| Mar 31, 2022 | -116.00 |
| Dec 31, 2021 | -115.00 |
| Jun 30, 2021 | -289.00 |
| Mar 31, 2021 | 6,969.00 |